This is a very significant news, a projection of $62.5 millions in revenues. I have done a PPS valuation post, one prior to this one. Have a look at the post if you have time, will give you some idea how big of a deal this news is.
I am in OWC*. It's trading at .70 cents. Both VDRM and OWC* are in R&D field focused on finding cure/treatment for many serious illnesses. However, VBDRM has given the market a clear guidance for estimated revenues in 2017. This is huge.
Both OWC* and VDRM will do well, they are in the similar space.
G0 $$VDRM$$
All imho, not an investment advice. Do your own DD and decide on your own.